PMID: 11931615Apr 5, 2002Paper

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics

Journal of Medicinal Chemistry
P S DragovichS T Worland

Abstract

The structure-based design, chemical synthesis, and biological evaluation of various 2-pyridone-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds are comprised of a peptidomimetic binding determinant and a Michael acceptor moiety, which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme. The 2-pyridone-containing inhibitors typically display improved 3CP inhibition properties relative to related peptide-derived molecules along with more favorable antiviral properties. The cocrystal structure of one pyridone-derived 3CP inhibitor complexed with HRV-2 3CP is also described along with certain ab initio conformation analyses. Optimization of the 2-pyridone-containing compounds is shown to provide several highly active 3CP inhibitors (k(obs)/[I] > 500,00 M(-1) s(-1)) that function as potent antirhinoviral agents (EC(50) = <0.05 microM) against multiple virus serotypes in cell culture. One 2-pyridone-containing 3CP inhibitor is shown to be bioavailable in the dog after oral dosing (F = 48%).

References

Jan 1, 1992·Annual Review of Microbiology·M A McKinlayM G Rossmann
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·P L CallahanR J Colonno
Oct 1, 1985·British Medical Bulletin·R J Phillpotts, D A Tyrrell
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M DuechlerE Kuechler
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J F Bazan, R J Fletterick
Oct 25, 1984·Nucleic Acids Research·G StanwayJ W Almond
Jan 1, 1994·Pharmacology & Therapeutics·L Carrasco
Jan 1, 1996·Medicinal Research Reviews·R S BohacekW C Guida
Jun 9, 1999·Bioorganic & Medicinal Chemistry Letters·C HamdouchiB A Heinz
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MatthewsS T Worland
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·A K PatickS T Worland
Jun 9, 2001·Antiviral Research·A C SchmidtR M Chanock
Aug 5, 1997·Chemical Reviews·Robert E. Babine, Steven L. Bender

❮ Previous
Next ❯

Citations

Dec 4, 2003·Bioorganic & Medicinal Chemistry·Regis Leung-ToungTim Fat Tam
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·N David KarisPeter C Healy
Mar 24, 2011·Future Medicinal Chemistry·Eugene N MuratovVictor E Kuz'min
Dec 29, 2015·The Journal of Organic Chemistry·Yunyun LiXingwei Li
Jun 1, 2010·Ultrasonics Sonochemistry·Enrique RuizNazario Martín
Feb 1, 2008·Pharmacology & Therapeutics·Nicole G HansbroPhilip M Hansbro
Apr 3, 2008·Medicinal Research Reviews·Armando M De PalmaJohan Neyts
Mar 19, 2016·Biochimica Et Biophysica Acta·Caiming WuTianwei Lin
Sep 19, 2006·The International Journal of Biochemistry & Cell Biology·Stephen CurryRobin J Leatherbarrow
Jun 2, 2010·The Journal of Allergy and Clinical Immunology·David J Jackson, Sebastian L Johnston
Jun 19, 2004·Bioorganic & Medicinal Chemistry Letters·Rajendra P Jain, John C Vederas
Jun 17, 2008·Bioorganic & Medicinal Chemistry Letters·Edite VerissimoPaul M O'Neill
Nov 8, 2014·Angewandte Chemie·Pavel A Donets, Nicolai Cramer
May 28, 2014·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Hacer Pir GümüşYusuf Atalay
Feb 1, 2018·Chembiochem : a European Journal of Chemical Biology·Brendan S ZhangJennifer A Prescher
Jan 27, 2015·Organic & Biomolecular Chemistry·Vemu NagarajuGalla V Karunakar
May 28, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Majed AlrobaianHany A Eldeab
Jun 21, 2019·Organic & Biomolecular Chemistry·Kunita Phakdeeyothin, Sirilata Yotphan
Oct 18, 2019·Chemical Communications : Chem Comm·Sardaraz KhanYong Jian Zhang
Dec 5, 2002·The Journal of Peptide Research : Official Journal of the American Peptide Society·R R Neubig
Feb 21, 2021·Bioorganic & Medicinal Chemistry Letters·Yun Zhang, Andrew Pike
Dec 9, 2004·Chemical Reviews·Wendy A LoughlinDavid P Fairlie
Apr 14, 2010·Chemical Reviews·Wendy A LoughlinDavid P Fairlie
Oct 9, 2019·Accounts of Chemical Research·Sierra J Williams, Jennifer A Prescher
Dec 12, 2002·Chemical Reviews·James C PowersKaren Ellis James

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.